Instructions Thyreoidea compositum solution for injection ampoule 2.2 ml No. 5
Composition
active substances: 2.2 ml of solution contain: Acidum alpha-ketoglutaricum D8 – 22 mg, Acidum fumaricum D8 – 22 mg, Acidum L(+)-lacticum D3 – 22 mg, Acidum malicum D8 – 22 mg, Adenosinum triphosphoricum D8 – 22 mg, Calcium fluoratum D10 – 22 mg, Colchicum autumnale D4 – 22 mg, Conium maculatum D4 – 22 mg, Corpus pineale suis D8 – 22 mg, Cortisonum aceticum D28 – 22 mg, Euspongia officinalis D8 – 22 mg, Fucus vesiculosus D6 – 22 mg, Funiculus umbilicalis suis D10 – 22 mg, Galium aparine D4 – 22 mg, Glandula thyreoidea suis D8 – 22 mg, Hepar suis D10 – 22 mg, Medulla ossis suis D10 – 22 mg, Natrium diethyloxalaceticum D8 – 22 mg, Pulsatilla pratensis D8 – 22 mg, Sedum acre D6 – 22 mg, Sempervivum tectorum ssp. tectorum D6 – 22 mg, Splen suis D10 – 22 mg, Sulfur D10 – 22 mg, Thymus suis D10 – 22 mg, Viscum album D3 – 22 mg;
Excipients: sodium chloride, water for injections.
Dosage form
Solution for injection.
Main physicochemical properties: transparent, colorless, odorless solution.
Pharmacotherapeutic group
A complex homeopathic preparation.
Pharmacological properties
The drug regulates the function of the thyroid gland, has a detoxification, lymphatic drainage, immunomodulatory, anti-inflammatory effect. The action of the drug is based on the normalization of impaired functions of the endocrine glands and the activation of the body's defenses due to the substances of plant, mineral and animal origin that are part of its composition.
Indication
In the complex treatment of thyroid dysfunction, to normalize the functions of the endocrine glands, as well as the functions of connective tissues, especially in precancerous conditions, hypernephromas, progressive muscular dystrophy, myxedema, fibroplastic induration of the penis, obesity, bronchial asthma, scleroderma, osteochondrosis and arthrosis, and adhesive disease.
Contraindication
Hypersensitivity to any component of the drug.
If acute inflammation and fever occur, treatment should be discontinued until the symptoms disappear.
Interaction with other medicinal products and other types of interactions
Unknown.
Application features
If symptoms persist or worsen, you should consult a doctor.
If you have thyroid disease, you should consult a doctor before using the drug.
This medicinal product contains less than 1 mmol sodium (23 mg) per dose, i.e. essentially 'sodium-free'.
Use during pregnancy or breastfeeding
Do not use the drug during pregnancy. There are no clinical data on the use of the drug during breastfeeding.
The ability to influence the reaction speed when driving or working with other mechanisms
Considering that sensitive patients may experience adverse reactions (decrease in blood pressure) during the use of the drug, they should refrain from driving or operating other mechanisms during the treatment period.
Method of administration and doses
Single dose: adults and children over 12 years of age – 1 ampoule of 2.2 ml. Apply as intramuscular, subcutaneous, intradermal, and if necessary, intravenous injections 1–3 times a week.
The course of treatment is 4–6 weeks.
Taking into account the characteristics of the course of the disease and the patient's condition, the doctor may change the duration of the treatment course and the method of application (injections into acupuncture points).
Opening the ampoule
Open carefully.
It is not necessary to cut the glass ampoule. Hold the ampoule with the top facing up at an angle; shake the liquid at the top of the ampoule downwards. Break off the top of the ampoule where the colored mark is.
Discard unused solution.
Children
The drug is recommended for the treatment of children aged 12 years and older.
Overdose
There may be an increase in the manifestations of adverse reactions.
Side effects
Hyperthyroidism may worsen.
In rare cases, nausea, stomach upset, dizziness, increased blood pressure or fluctuations in blood sugar levels may occur. Occasionally, changes may occur at the injection site. In this case, treatment should be temporarily interrupted.
A decrease in body temperature, local inflammatory reactions around the subcutaneous injection site, and a short-term slight enlargement of regional lymph nodes are not considered harmful.
In case of mistletoe intolerance, isolated cases of local or systemic allergic or allergy-like reactions may occur, such as widespread itching, urticaria, rash, facial swelling (Quincke's edema), tremor, convulsions, difficulty breathing, sudden decrease in blood pressure; such reactions require discontinuation of the drug and immediate medical attention.
Sometimes there may be activation of inflammation (chronic sinusitis, radicular granulomas).
Expiration date
5 years.
The expiration date determines the use of the drug until the last day of the specified month.
Storage conditions
Store in the original packaging at a temperature not exceeding 25 °C.
Keep out of reach of children!
Incompatibility
Unknown. The medicinal product should not be mixed with other medicinal products in the same container, except those manufactured by Biologische Heilmittel Heel GmbH.
Packaging
5 (5×1), 10 (5×2) or 100 (5×20) ampoules of 2.2 ml in a cardboard box.
Vacation category
According to the recipe.
Producer
Biologische Heilmittel Heel GmbH /
Biologische Heilmittel Heel GmbH.
Address
Dr. Reckeweg-Strasse 2-4, 76532 Baden-Baden, Germany /
Dr. Reckeweg-Str. 2-4, 76532 Baden-Baden, Germany.
